Amouyal Philippe has filed 19 insider transactions across 2 companies since April 2023.
Most recent transaction: a grant/award of 35714 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on May 01, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Restricted Stock Units | 35714 | $0.00 | 35,714.0000 | 365,780,799 | 9999.99% | 0.01% |
| May 1, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Stock Option (Right to Buy) | 43478 | $0.00 | 43,478.0000 | 365,780,799 | 9999.99% | 0.01% |
| June 20, 2025 | CAVA GROUP, INC. | $CAVA | Amouyal Philippe | Director | A | Common Stock | 1767 | $0.00 | 18,074.0000 | 118,273,000 | 10.84% | 0.00% |
| June 3, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| May 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | M | Common Stock | 36810 | $0.00 | 285,174.0000 | 363,020,303 | 14.82% | 0.01% |
| May 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| June 20, 2024 | CAVA GROUP, INC. | $CAVA | Amouyal Philippe | Director | A | Common Stock | 1307 | $0.00 | 16,307.0000 | 63,448,000 | 8.71% | 0.00% |
| May 13, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | M | Common Stock | 8032 | $0.00 | 248,364.0000 | 0 | 3.34% | 0.00% |
| April 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 17, 2023 | CAVA GROUP, INC. | $CAVA | Amouyal Philippe | Director | P | Common Stock | 10000 | $33.18 | 15,000.0000 | 1,328,000 | 200.00% | 0.75% |
| Nov. 13, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | P | Common Stock | 200000 | $1.01 | 240,332.0000 | 0 | 495.88% | 0.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Amouyal Philippe | Director | A | Common Stock | 5000 | $0.00 | 5,000.0000 | 1,328,000 | 9999.99% | 0.38% |
| May 21, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 21, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | M | Common Stock | 9302 | $0.00 | 40,332.0000 | 0 | 29.98% | 0.00% |
| April 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Amouyal Philippe | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |